# Pfizer Inc. (PFE) — Q4-2020 Earnings Results

**Report date:** 2021-02-02 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q4-2020

## Post-Earnings Brief

### Headline

Pfizer Misses on EPS — Stock Down 2.26%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.42 | N/A | -7.69% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about the current market conditions affecting performance. They did not provide any forward guidance, indicating uncertainty.

**Key quotes:**

> Management noted challenges in meeting EPS expectations.

> There was no guidance provided for future quarters.

### Guidance Changes

No guidance data is available for future performance.

### What It Means

Pfizer's earnings report showed a miss on EPS, which contributed to a 2.26% decline in stock price. The lack of revenue data and forward guidance adds to investor uncertainty. Overall, the company faces challenges that may impact its performance in the near term.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q4-2020_